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USE OF SPECT DIFFERENCE IMAGING TO ASSES S SUBCORTICAL BLOOD FLOW CHANGES 
DURING EPILEPTIC SEIZURES. Andrew D. Norden and Hal Blumenfeld.  Departments of Neurology 
and Neurobiology, Yale University School of Medicine, New Haven, CT.  
 
Seizures are thought to arise primarily from the cerebral cortex. However, the propagation and behavioral 
manifestations of seizures involve a network of both cortical and subcortical structures. The medial 
thalamus and upper brainstem reticular formation are crucial areas for the maintenance of normal 
consciousness. Bilateral involvement of these structures may be responsible for loss of consciousness 
during partial seizures. Therefore, we sought to investigate the role of the medial thalamus and brainstem in 
seizures.  We performed SPECT ictal-interictal difference imaging co-registered with high-resolution MRI 
scans to localize regions of cerebral blood flow changes in patients undergoing inpatient monitoring for 
epilepsy. Ictal-interictal SPECT scans from 43 seizures in 40 patients were analyzed. The medial thalami 
showed SPECT difference imaging changes of >20% in 18 patients.  Of patients with medial thalamic 
changes, the majority (13 of 18) had seizure onset in the temporal lobe, while only 1 had confirmed onset in 
extratemporal structures, and the remainder were non-localized. In contrast, in the 22 patients without 
>20% SPECT changes in the medial thalami, 6 had extratemporal onset, 6 had temporal onset, and the 
remainder were non-localized.  In patients with temporal lobe seizures, the side of greater medial thalamic 
and brainstem reticular formation involvement was strongly related to SPECT injection timing such that 
there was a sequential pattern of ipsilateral followed by contralateral changes.  Brainstem structures showed 
>20% SPECT changes in 27 of 43 seizures with no clear relation to temporal or extratemporal onset.  We 
conclude that the medial thalamus is preferentially involved in seizures arising from the temporal lobes, 
possibly reflecting the strong connections between limbic temporal structures and the medial thalamus. 
Sequential involvement of ipsilateral followed by contralateral structures in the medial thalamus and upper 
brainstem may explain how seizures produce peri-ictal loss of consciousness despite incomplete 
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The word epilepsy comes from a Greek word that means “to be seized by forces from without.”  
Interestingly, it is from this definition that the word seizure is derived as well.  Apparently, early physicians 
and scientists believed that patients with epilepsy were infected with dangerous supernatural beings.  
Modern medical science is more comfortable with the assumption that epilepsy is caused by an organic 
brain defect.  Indeed, a number of epileptic syndromes are caused by discrete cerebral lesions, often the 
result of developmental defects, trauma, cerebrovascular disease, tumors, tissue atrophy, or infection.  
There are also some forms of epilepsy (idiopathic epilepsies), most notably those which are characterized 
by absence (petit  mal) seizures, for which no diseased portion of brain is currently identifiable.  
Epilepsy is a disorder characterized by paroxysmal, excessive, and disorderly discharging of 
neurons that generally produces clinical manifestations in the form of recurrent seizures.  In some cases, 
this hyperactive neuronal state can be detected by a physician with electroencephalographic (EEG) 
recording.  The signs and symptoms of epileptic seizures are numerous, and they often depend on the type 
of seizure that one observes.  Seizures are classified as partial or generalized, the former originating from a 
distinct focus in the brain and the latter appearing to occur everywhere at once.  Partial seizures are further 
classified as simple partial (with no impairment of consciousness), complex partial (with impairment or 
loss of consciousness), or partial seizures that evolve to secondarily generalized seizures.  Partial seizures 
are characterized by a wide variety of symptoms that may be predicted by the portion of brain from which 
the seizures originate.  These may include motor, sensory, autonomic, or psychological components.  
Generalized seizures occur in many subtypes as well:  absence (petit mal), myoclonic, tonic, atonic, clonic, 
and tonic-clonic (grand mal) seizures.  Each of these involves very different manifestations, so they will 
not all be discussed here.  However, it is worth mentioning that the initial, tonic phase of a tonic-clonic 
seizure often includes increased muscle tone with a rigid, flexed posture followed by a rigid, extended 
posture.  During the next part of the seizure, the clonic phase, the patient experiences bilateral rhythmic 
jerks of the whole body.  All of this occurs in the absence of consciousness, and it is typically followed by a 
confused, drowsy state or by a brief period of coma 1. 
 The prevalence of epilepsy is reported to be between 5 and 8 people per 1,000, or approximately 





therapy with anti-epileptic drugs 1.  However, there are between 50,000 and 300,000 people in the U.S. 
whose seizures are not adequately controlled by therapy with one drug or with any comb ination of drugs 2, 
3.  These individuals are said to have medically intractable epilepsy.  The primary treatment option 
available to these patients is epilepsy surgery in which the diseased portion of brain is removed after 
accurate localization of the seizure focus.  As one might expect, surgery is only a possibility for epileptic 
syndromes that produce partial seizures; generalized seizures do not, by definition, have a discernible 
focus.  Furthermore, many considerations must be taken into account by a patient who may be a candidate 
for epilepsy surgery.  The degree to which seizures affect a patient’s quality of life is obviously an 
extremely important factor, as is the likelihood that the diseased portion of brain can be resected without 
significant loss of function.  
 For patients who elect to have epilepsy surgery, accurate localization of the focus is absolutely 
crucial to success.  A localized EEG abnormality at the beginning of a seizure is typically taken to indicate 
the location of the focus.  However, scalp EEG recordings may be unreliable and inaccurate 4, 5.  When 
scalp EEG fails to localize the zone of seizure onset, depth electrodes are often implanted intracerebrally 
and subdurally so that chronic recordings with minimal interference from non-neuronal tissue are possible.  
Because depth electrode implantation carries with it substantial risk and expense, efforts have recently been 
directed toward developing noninvasive means of precise focus identification.  Such techniques include 
18F-fluorodeoxyglucose positron emission tomography (FDG-PET), which is used to measure cerebral 
glucose uptake, and 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) single-photon emission 
computed tomography (SPECT), which measures regional cerebral blood flow (rCBF).  These imaging 
modalities are logical choices for seizure focus localization because of the typical changes in blood flow 
and metabolism that accompany seizures. 
 Because neurons require a continuous source of ATP for electrical signaling, and because ATP 
synthesis requires a blood-delivered supply of glucose, rCBF is generally accepted as a measure of 
neuronal activity in brain tissue.  As epileptic seizure activity involves excessive neuronal firing, it is not 
surprising that rCBF increases substantially during epileptic seizures.  This finding was first reported in 
1939 by Wilder Penfield and his colleagues 6.  Indeed, ictal SPECT studies of patients with partial seizures 





a decrease in rCBF often in the same regions that are ictally hyperperfused 7.  Parallel findings have been 
demonstrated using PET, that is, ictal PET scans show areas of hypermetabolism while interictal scans 
suggest hypometabolism 3, 8, 9.  PET studies in humans and radiographic studies in rats also point to a 
global increase in glucose metabolism in the ictal state followed by a global decrease when the seizure ends 
10.  However, ictal PET studies are difficult to interpret because PET scanning has poor time resolution in 
comparison to SPECT scanning.  Whereas a SPECT scan reflects blood flow during a 30 – 60 second 
window, the PET technique reflects metabolism during a 30 – 45 minute period.  In addition, the situation 
as assessed with SPECT and PET may be more complicated than these findings suggest because of the 
recently detected uncoupling of metabolism and blood flow.  Using a rat model of epilepsy in which 
seizures are induced with intracerebral penicillin injections, Bruehl and colleagues showed significant 
differences in the degree to which blood flow and glucose uptake are increased at the epileptic focus.  They 
also found intriguing differences between blood flow and metabolism in cortical areas close to the focus, in 
remote portions of the ipsilateral cerebral hemisphere, and even in the ventrolateral and posterior thalamic 
nuclei on the same side as the seizure focus.  Control rats that did not receive penicillin showed close 
coupling of blood flow and metabolism everywhere in the brain 11.  An additional complicating factor is 
that, for unknown reasons, interictal hypometabolism has been far easier to detect in humans when the 
seizure focus is in the temporal lobe than when seizures commence in the frontal lobe 12.   
 Though the interpretation of blood flow and metabolism data is not always straightforward, PET 
and SPECT have improved the ability of neurosurgeons to localize a seizure focus 13-15.  Since 1995, a 
team of Yale researchers headed by George Zubal and Susan Spencer has been using computer-aided 
processing of SPECT images to further improve the localizing ability of SPECT scans; this work may 
ultimately be extended to PET and other imaging modalities.  SPECT measures blood flow by detection of 
an intravenously-injected tracer substance, typically, 99mTc-HMPAO.  99mTc-HMPAO SPECT scanning is a 
particularly versatile method because the tracer crosses the blood-brain barrier within 30 – 60 seconds after 
injection, binds tightly to brain tissue, and does not redistribute for 6 – 8 hours.  Thus, tracer injection 
during a seizure with SPECT scanning an hour or more later allows for visualization of rCBF in the ictal 





Figure 1.  This image represents a three-dimensional MRI reconstruction of 
one patient’s brain.  The SPECT difference image is super-imposed on the 
MRI with red areas representing ictal hyperperfusion and blue areas ictal 
hypoperfusion.  As is evidenced by strong temporal lobe hyperperfusion, the 
ictal SPECT scan used to prepare this image was acquired during a temporal 
lobe seizure.  Note that large areas of frontal, parietal, and occipital cortex 
are hypoperfused at the same time. 
modalities than with SPECT.  Zubal and Spencer’s technique relies on computer software that co-registers 
an ictal and an interictal SPECT image.  The software then subtracts the two SPECT images and generates 
a “difference image.”  
This image highlights 
areas of increased and 
decreased blood flow 
during a seizure, and it 
also indicates the 
magnitude of changes in 
rCBF.  The difference 
image may be 
superimposed onto a 
high-resolution structural 
magnetic resonance 
imaging (MRI) scan of 
the patient’s brain; this 
allows one to determine 
which brain structures are 
preferentially hyper- and hypoperfused during a seizure as shown in Figure 1 3.  By carefully applying this 
image processing technique, one may learn a great deal about which brain structures are important in 
seizure origination, propagation, and regulation. 
Sometimes using techniques similar to Zubal and Spencer’s, many research groups have 
conducted SPECT studies in recent years to analyze rCBF during seizures.  The majority of these studies 
examine rCBF in cerebral cortex because epileptic seizures have long been thought to commence in 
neocortex and spread to brainstem and subcortical structures 8.  As explained previously, studies of cortical 
blood flow often show ictal hyperperfusion at the seizure focus with interictal hypoperfusion at the same 
site.  However, there is no reason to believe that the clinical manifestations of seizures depend solely on 





as the cerebellum and brainstem may be important for some aspects of seizure development or expression.  
The basal ganglia are thought to play a role because of the complex motor manifestations of some seizures.  
The thalamus has been implicated in seizures because of its unique electrophysiological properties and 
massive connections with cerebral cortex; indeed, recent functional magnetic resonance imaging (fMRI) 
studies demonstrate a close coupling of cortical and thalamic metabolism during seizures 17.  The 
cerebellum is an area of interest because of the increased likelihood of cerebellar atrophy in patients with 
long-standing partial epilepsy (as compared to healthy individuals).  This atrophy occurs for unknown 
reasons, but it may well yield clues to the pathophysiology of epilepsy 18.   
Thus, in addition to cerebral cortex, scientists have used SPECT to study a number of subcortical 
structures and the cerebellum.  In all of these structures, ictal changes in rCBF have been observed, 
although they have not always been consistent with respect to laterality or direction of change.  Since more 
of these studies examined cerebellum than either basal ganglia or thalamus, cerebellar blood flow will be 
considered first.  The most common finding of cerebellar SPECT studies is crossed cerebellar 
hyperperfusion (CCH) in which the cerebellar hemisphere contralateral to the epileptic focus shows 
increased blood flow during the ictal state.  This has been reported in patients with various types of partial 
epilepsy 18, 19, with frontal lobe epilepsy 20, with epilepsy of the supplementary sensorimotor area 
(SSMA) 21, and with partial complex seizures related to herpes simplex encephalitis 22.  CCH was found 
in these studies to occur in as few as 33% of patients studied 19 or in as many as 100% 21.  Patients 
without CCH showed ipsilateral cerebellar hyperperfusion, bilateral cerebellar hyperperfusion, or no 
significant change in perfusion.  Note that cerebellar hypoperfusion was never observed during seizures.  
However, as one might expect, there are reports of interictal hypoperfusion of cerebellum in children with 
partial epilepsy 23.  This study reports that interictal hypoperfusion may be ipsilateral or contralateral to the 
epileptogenic focus, and bilateral hypoperfusion was observed as well.  Finally, there was one recent report 
of epileptic seizures that originate in the cerebellum 24.  Harvey and his colleagues at Miami Children’s 
Hospital present a 6-month old female patient with a left cerebellar ganglioglioma.  Using scalp and 
intracranial EEG, MRI, CT, and SPECT, they confirm that this patient’s seizures, which consist of left 





have their origin in the diseased region of the cerebellum.  After surgical removal of the tumor, this 
patient’s seizures resolved completely.        
Similar studies have been performed with attention paid to the basal ganglia.  In their study of 8 
patients with SSMA seizures, Laich et al. report that some patients showed ipsilateral hyperperfusion of the 
basal ganglia, some showed bilaterally symmetric or asymmetric hyperperfusion, and one patient exhibited 
no change in perfusion 21.  All of these patients had significantly more blood flow to the basal ganglia than 
did healthy controls.  Another study demonstrates ictal hyperperfusion of the ipsilateral basal ganglia in 2 
of 5 patients with complex partial seizures that originate in posterolateral cortex 25.  Similar findings have 
been reported in patients with temporal lobe epilepsy; one study of 42 patients with temporal lobe epilepsy 
reports a statistically significant mean increase in basal ganglia perfusion of 8% during seizures 26.  
Individual cases are not reported in this study, so it is unclear whether the basal ganglia changes occur 
ipsilaterally, contralaterally, or bilaterally.  Furthermore, the number of patients who actually show basal 
ganglia hyperperfusion is not apparent.  An interesting additional result, however, is that basal ganglia 
perfusion in these patients correlates with upper limb dystonia such that increased asymmetry of basal 
ganglia perfusion during seizures occurred more often in patients with unilateral upper limb dystonia.  In 
addition, the group of patients whose seizures involved unilateral dystonia showed a mean increase in basal 
ganglia perfusion of 9.5%, while the group of patients who did not have dystonia showed a mean increase 
of only 4.4%.  Finally, interictal hypoperfusion has been shown for the basal ganglia as well.  In 4 of 20 
patients with medically refractory complex partial seizures, one study found basal ganglia hypoperfusion; 3 
of these patients showed ipsilateral hypoperfusion, and the fourth patient showed hypoperfusion 
contralaterally 27.        
The third subcortical structure that has been studied in some depth using SPECT is the thalamus.  
Reports concerning the thalamus are very similar to those discussed for cerebellum and basal ganglia.  For 
example, one of the same studies that demonstrates CCH mentions ipsilateral increases in thalamic 
perfusion during seizures; unfortunately, the magnitude of increased thalamic perfusion is not mentioned, 
and this result pertains only to one patient 20.  One study also reports that 26% of 67 patients with temporal 





contralateral hypoperfusion, ipsilateral hyperperfusion, or bilateral changes in thalamic perfusion 28.  Note 
that these findings are in line with PET studies which show similar subcortical metabolic changes in 
patients with temporal lobe epilepsy. 
Clearly, a substantial amount of research effort in this field has been devoted to subcortical 
structures.  It is also clear that the results obtained to date are difficult to understand; though changes in 
perfusion have been observed, the significance of these changes remains to be determined.  Additionally, 
the described changes are often reported to occur in only a small subset of patients.  There has been little 
speculation as to why certain patients show these changes and why many do not.  There may well be 
methodological issues that must be resolved before these studies will yield fruit.  Also, many of these 
studies use small numbers of patients because of the technical difficulty of the experiments.  Patient cohorts 
often comprise a wide range of ages and types of epilepsy, so the results are not as generalizable as they 
might otherwise be.  That being said, these studies have revealed interesting and clinically relevant 
information.  Though the results have not yet dramatically altered the face of epilepsy therapy, these studies 
provide one of the only tools that allows physicians to examine brain activity during seizures.  Accordingly, 
it is surprising that there is no report in the literature of a SPECT study that examined rCBF in the 
brainstem and thalamus during seizures.    
The brainstem reticular formation and related structures are thought to be involved in modulating 
the excitability of neurons in cerebral cortex; thus, researchers tend to think of the brainstem as a group of 
structures that have a primarily regulatory role on cortical seizure activity 8.  However, a small number of 
animal studies during the 1980’s and early 1990’s suggest a significant role for the brainstem in 
propagation and maintenance of various seizure types.  For example, two independent groups of 
researchers determined that seizure activity requires a functional substantia nigra.  One research team 
inhibited the pars reticulata of the rat substantia nigra (SNR) with muscimol, a γ-aminobutyric acid (GABA) 
agonist, and found that seizure activity was substantially inhibited.  These rats were highly prone to 
seizures because of “kindling,” an experimental paradigm in which electrical stimulation is repeatedly 
applied to the amygdala.  Initially, the electrical stimulus is insufficient to elicit a seizure, but after repeated 
stimulation, the stimulus causes a seizure every time it is applied.  In these rats, muscimol treatment of the 





before injection of the drug.  Increased stimulation intensity, however, was able to elicit seizures with 
regularity.  Note that kindling from sites other than the amygdala is also effective in producing seizures; 
muscimol treatment of the SNR blocked seizures kindled from the entorhinal cortex and olfactory structures 
with similar potency.  In all cases, muscimol injections were effective only when they were localized 
precisely to the SNR.  Surrounding structures were not equally or even similarly effective.  As would be 
expected, these authors report the same results when an inhibitor of GABA breakdown was injected into 
the SNR and also when the SNR was bilaterally destroyed by N-methyl-D-aspartate, a neurotoxin 29. 
A second group of researchers also determined that bilateral lesions of the SNR have a protective 
effect against seizures 30.  In this study, seizures in rats were induced using one of two paradigms, 
intravenous bicuculline (a GABA antagonist) or maximal electroshock (MES) in which the head is 
electrically stimulated.  They found that bilateral SNR lesions significantly attenuated seizures activity 
induced by either paradigm; for seizures induced by bicuculline, higher doses of the drug were effective in 
eliciting seizures after SNR lesioning, thus suggesting that SNR lesions do not eliminate the potential for 
seizure generation.  In MES seizures, SNR lesions blocked specifically the tonic hindlimb extension (THE) 
component, a hallmark of MES seizures, thus supporting the notion that MES seizure regulatory sites are 
somehow involved with the extrapyramidal motor system.  These findings are analogous to the result in the 
previously discussed study that increased stimulation intensities were required to produce seizures after 
SNR lesions.  Because previous studies demonstrated conclusively that electrical or chemical stimulation of 
the SNR fails to initiate seizures, it seems most likely that the SNR is involved in amplification or 
sustenance of seizure activity generated elsewhere in the brain 31.  These results are in line with an earlier 
study of generalized motor seizures induced by amygdala kindling in rats which showed increased glucose 
uptake bilaterally in the substantia nigra during seizures 32. 
Besides the substantia nigra, the brainstem reticular formation (RF) has often been implicated as 
having an important regulatory role in seizures.  An important set of experiments conducted in the 1950’s 
demonstrated that stimulation of the RF in the medulla, pons, or midbrain of rats and cats could induce 
seizures 33.  These were characterized by tonic limb extension, much like MES seizures, and there was no 
evidence of hypersynchronized activity in the forebrain.  Thus, it seemed that seizures, or at least the tonic 





after precollicular transection, and they could not be induced by stimulation rostral to the midbrain.  These 
findings clearly indicated that the forebrain was not required for behavioral expression of at least one type 
of seizure.  Transection studies in rabbits  around the same time suggested that the tonic components of 
MES seizures required an intact pons 34.  Again, precollicular transection failed to alter tonic seizure 
components.    
 During the 1980’s, a series of experiments conducted by Ronald Browning and his colleagues at 
South Illinois University School of Medicine verified earlier findings.  First, they lesioned the superior 
cerebellar peduncle (SCP) or midbrain RF in rats and attempted to induce seizures using the MES 
paradigm.  They found that the THE response was substantially attenuated by mechanical lesions to either 
structure 35.  In a subsequent paper, they showed that these lesions had no effect on the clonic components 
of seizures induced by a number of methods 36.  The same group went on to show that they could eradicate 
the tonic components of seizures with a smaller lesion than they had previously used.  They lesioned the 
nucleus reticularis pontis oralis (RPO), a part of the pontine and mesencephalic RF, along with the SCP and 
were able to effectively eliminate the tonic components of sound-induced seizures in genetically epilepsy-
prone rats (GEPR) and MES seizures in normal rats 37.  However, the clonic component of audiogenic 
seizures (running and bouncing clonus) was also attenuated by the RPO/SCP lesions.  This was an 
interesting finding because these lesions affected the tonic components of a variety of seizure types while 
sparing the clonic components (face and forelimb clonus).  It quickly became clear that running and 
bouncing clonus is different from face and forelimb clonus in that it depends on the brainstem and not on 
the forebrain for expression.  This realization occurred after rats with precollicular transections failed to 
display face and forelimb clonus when exposed to electroshock or pentylenetetrazol (PTZ) seizure-
induction paradigms 38.  Both electroshock and PTZ-induced seizures typically contain a face and forelimb 
clonic component. 
Using transection experiments and multi-unit recordings in cats, a group of scientists in Mexico 
during the early 1980’s sought to further define the importance of the brainstem RF in the behavioral 
manifestations of seizures.  This group had shown previously that PTZ-induced seizures begin in the 





seizure activity spread from RF to the spinal cord was unclear, that is, activity may have propagated via 
cortex and the pyramidal tract or it may have used “extrapyramidal” pathways.  By recording multi-unit 
activity from the pyramidal tract while monitoring musculature with electromyography (EMG), it was 
shown that there was no correlation in time between the increase of pyramidal tract activity and the onset of 
clinical and EMG seizures.  In contrast, the change in firing rate of RF neurons was chronologically related 
to the seizure activity.  Based on these results, the authors conclude that seizure activity in the RF 
propagates to the spinal cord via “extrapyramidal” pathways.  Note that these results do not dismiss the 
pyramidal pathway as unimportant for seizure activity; rather, an increase in pyramidal tract multi-unit 
firing was associated with a further increase in EMG activity, thus suggesting some kind of facilitatory role 
for the cortex and pyramidal tract in PTZ-induced seizures 40.  Subsequent experiments sought to better 
define the region of the RF that was most important in PTZ-induced seizure generation and concluded, 
based on “pretrigeminal” transections, that the mesencephalic RF was activated first and drove other areas 
41.  This finding was verified using transections within the midbrain 42. 
This view, that PTZ-induced seizures begin in the mesencephalic RF, is by no means uncontested.  
Magistris et al. performed a thorough study in 1988 to characterize the roles of the forebrain, brainstem, 
and spinal cord in PTZ-induced seizures 43.  They studied intact cats as well as cats with precollicular 
transections, spinal cord transections, or both transections.  These animals were monitored with EEG and 
EMG, and they received PTZ injections of various doses.  In animals with precollicular transections, 
cortical EEG showed seizure activity that was very similar to that observed in intact cats.  However, 
functional disconnection of the forebrain did inhibit the clonic motor components of these seizures.  These 
results bolster the argument that the forebrain is critical for clonic seizure activity and that such activity is 
initiated in the forebrain.  Magistris’ group therefore concludes that the mesencephalic RF is not necessary 
for cortical seizure activity to occur.  They point out that the multi-unit recordings of Velasco et al. are 
highly filtered and may actually represent activity in pathways descending from the forebrain to the spinal 
cord. 
In humans, some recent compelling evidence for a key brainstem function in epileptic seizures 
comes from vagus nerve stimulation therapy.  One study showed that left cervical vagus nerve stimulation 





Vagus nerve stimulation directly activates neurons in brainstem nuclei that give rise to vagus nerve 
efferents and receive vagal afferents.  These include the dorsal motor nucleus of the vagus and the nucleus 
tractus solitarius, respectively.  It is not yet known why vagus nerve stimulation reduces the frequency of 
epileptic seizures, but brainstem structures are quite likely to be involved.       
Though the precise role of the brainstem in epilepsy remains to be clarified, then, ample evidence 
suggests that the propagation and behavioral manifestations of seizures involve a network of cortical and 
subcortical structures.  This fact may be exploited by scientists who are interested in the neural mechanisms that 
underlie consciousness.  In a generalized seizure, consciousness is lost due to bilateral, diffuse involvement of 
cerebral cortex with synchronized electrical activity.  Partial seizures involve much smaller regions of cortex, yet 
patients are often observed to have impaired consciousness during the ictus.  Animal studies in 1949 showed 
conclusively that the thalamus and pontomesencephalic reticular formation are crucial areas for the maintenance 
of normal consciousness 44, 45.  More recently, rCBF in the medial thalamus and brainstem reticular formation 
has been shown to correlate with level of consciousness in healthy human volunteers 46.  Furthermore, it is 
known that the medial temporal structures have strong reciprocal connections with structures in the medial 
thalamus such as the mediodorsal nucleus and midline thalamic nuclei 47.  There are also connections 
between the medial temporal lobes and brainstem.  Therefore, it may be hypothesized that bilateral 
involvement of the medial thalamus and pontomesencephalic reticular formation is responsible for loss of 
consciousness during seizures despite only partial involvement of the cortex.  Theoretically, increased 
activity in the medial thalamus and brainstem reticular formation might produce widespread cortical 





Statement of Purpose 
We hope to determine, using SPECT, whether there are changes in rCBF in the medial thalamus 
and brainstem reticular formation during seizures.  Our goals are to fully characterize any observed changes 
with respect to laterality, magnitude, and timing; to determine where these changes occur with reasonable 
anatomical accuracy; and to determine whether these changes have any behavioral correlates.  By 
answering these questions, we hope to achieve a deeper understanding of the thalamus’ and brainstem’s 
role in the pathophysiology of impaired consciousness in epilepsy.  This work will shed light on the neural 
substrate that underlies consciousness in general as well.  Ultimately, an understanding of the mechanisms 
that modulate arousal states may lead to novel therapies for epilepsy, sleep disorders, and coma.  
Furthermore, the neural machinery that is responsible for the normal maintenance of consciousness may be 
organized very similarly to that which controls other sophisticated human functions such as thought.  If 
indeed there are brainstem and thalamic structures that impact consciousness by widespread cortical 





Figure 2.  Raw SPECT images have this appearance prior to 
normalization.  The scale on the right indicates magnitude of 
perfusion; red areas are highly perfused, whereas blue areas 
receive minimal blood flow. 
Methods  
Patient selection :  40 subjects with intractable seizure disorders were chosen from the cohort of patients 
referred to the Yale Epilepsy Program between 1993 and 2001.  Subjects were chosen for study if they had 
MRI, ictal SPECT, and interictal SPECT scans of suitable quality.  Though many of these subjects went on 
to have intracranial electrodes placed for improved seizure localization, data obtained during the 
preliminary non-invasive evaluation was used for the purposes of this study.  Patients were excluded if they 
had previous brain surgery or gross abnormalities of the brain.  Additionally, patients whose seizures were 
likely to be nonepileptic in nature were excluded.  
Patient evaluation :  As part of the standard pre-surgical evaluation, each patient gave a detailed history and 
underwent a general and neurological examination.  Diagnostic testing included a high-resolution MRI 
scan, PET scan, ictal SPECT scan, interictal SPECT scan, continuous scalp EEG with audio-video 
monitoring, detailed neuropsychiatric testing, and Wada testing.  PET scans were obtained following the 
intravenous (IV) injection of 10 mCi of 18F-FDG.  Transverse image reconstruction was performed with 
reoriented tomograms displayed in the axial, coronal, and saggital planes.  Many patients whose seizures 
remained poorly localized after this battery of non-invasive tests had intracranial depth electrodes placed 
and additional in-patient monitoring.  A variety of clinical information was collected for each patient, 
including seizure localization, 
seizure type and duration, injection 
time, and surgical outcome and 
pathology when applicable.  Seizure 
type and duration were determined 
by video review of the seizure 
during which the SPECT agent was 
injected.  All videotapes were 
reviewed by the same epileptologist 
along with a medical student.  
Seizure duration and SPECT 





respect to the beginning and end of the electrographic and behavioral seizure.  Concordance of findings on 
EEG, MRI, PET, SPECT, neuropsychiatric testing, Wada testing, and surgical outcome were used to 
classify seizures as temporal, extratemporal, or of uncertain onset.     
Ictal-Interictal SPECT Study:  99mTc-HMPAO was injected for SPECT studies.  As discussed earlier, this 
radiopharmaceutical agent rapidly enters the brain in proportion to cerebral blood flow and becomes 
trapped within cells.  Cerebral uptake is more than 90% complete within 60 seconds following the IV 
injection48, and since the tracer tightly binds to brain tissue, accurate scans may be obtained hours after the 
seizure ends.  Ictal injections of 20mCi 99mTc-HMPAO were made during seizure activity or as soon as 
possible after seizure cessation.  The patients were continuously monitored with video and EEG during this 
phase.  As soon as seizure activity was witnessed, an epilepsy fellow or EEG technician quickly injected 
the 99mTc-HMPAO intravenously.  Interictal injections were performed in patients who were free of seizure 
activity for 24 hours or more.  SPECT images were typically acquired within 90 minutes after injection 
using a three-headed Picker PRISM 3000 camera (Picker International, Cleveland Heights, OH).  
Projection data were acquired over 40 minutes on the PRISM 3000 mounted with ultra-high-resolution, 
parallel-hole collimators.  A 128 x 128 matrix resolution was used with a 1.6 magnification factor.  
Transverse slices were reconstructed using a routine clinical filtered back projection algorithm with Chang 
Figure 3.  Typical Rview layout with an MRI scan, interictal SPECT scan, ictal SPECT scan, and 
SPECT difference image (from left to right).  The two SPECT scans are normalized to account for 






attenuation correction; the attenuation coefficient was 0.11/cm.  The available reconstruction package 
allows prefiltering of the projection data using a selectable Butterworth filter whose cut-off frequency can 
be set to the position at which the image power spectrum is equal to the noise level in the projection 
images.  Approximately 30-40 transverse slices covering the whole brain were reconstructed using the 
ramp filter. 
Image manipulation:  Rview, proprietary software designed by Colin Studholme, PhD15, was used to 
analyze SPECT images (Figure 2).  The software runs on a Microsoft Windows platform.  For each patient, 
an ictal and an interictal SPECT image were acquired as described above.  A high-resolution MRI scan was 
obtained as well.  Both SPECT images and the MRI scan were aligned in three-dimensional space using a 
sophisticated mathematical algorithm that ensured optimal alignment.  The software then normalized the 
two SPECT images according to total pixel counts in the brain to account for any global differences in 
tracer uptake between the scans.  The SPECT images were subsequently subtracted, pixel-by-pixel, to yield 
a SPECT difference image, as shown in Figure 3.  The difference image was then superimposed on the 
MRI scan so that areas of hyper- and hypoperfusion during the ictus could be readily identified.  Positive 
differences represent increases in perfusion and are displayed in green, while negative differences represent 
decreased perfusion and are displayed in red.  The 
magnitude of blood flow changes is indicated by the 
intensity of the green or red color and can be measured 
in Rview quite easily.  
Regions of interest (ROIs) :  ROIs were drawn to 
identify SPECT CBF changes in the thalamus and 
brainstem.  The anatomical locations of CBF changes 
in the thalamus were based on high-resolution MRI 
images using anatomical criteria defined by Potts et al 
(Figure 4) 49.  The borders of the thalamus were 
defined medially as the third and lateral ventricles, and 
laterally as the internal capsule.  The medial thalamus 
was defined as the middle third of the thalamus in the anterior to posterior axis and the medial half in the 
Figure 4.  Example anatomical boundaries 
used to define the thalamus and to subdivide 
the thalamus into lateral and medial regions, 
based on each individual’s MRI scan.  
Red=right lateral thalamus, green=right 
medial thalamus, blue=left lateral thalamus,  
yellow=left medial thalamus. In the top 
panels, the regions are filled in with color; in 
the bottom panels the same regions are 





medial to lateral axis, running parallel to the lateral border.  The medial thalamic region thus defined 
includes the mediodorsal nucleus and is also likely to include the midline and intralaminar thalamic nuclei.  
Similar anatomic criteria were used to define the tegmentum of the upper pons and midbrain.  
Data acquisition :  SPECT ictal-interictal difference images were superimposed on MRI scans for review.  
Using visual inspection, one could now readily identify perfusion changes within the thalamus or brainstem 
RF.  Scans were systematically reviewed, and all perfusion changes within these areas were measured with 
Rview and recorded.  Changes of greater than 20% were accepted as significant.  All scans were reviewed 
by two observers who were blinded to the patients’ clinical information at the time of review, and the 

































T  complex 
partial (CPS) 
120 (+) 30 yes yes 
2 
right temporo-
occipital or right 
anterior 
temporal 
T  CPS 240 (-) 180 yes yes 
3 











sGTCS ) (+) 44 yes no 
4 left entorhinal 
cortex 
T  CPS 53 (+) 23 yes no 
5 
left entorhinal 




T  CPS 76 (+) 45 yes yes 
6 left temporal 
neocortex 
T  simple 
partial (SPS) 
74 (+) 8 yes yes 
7 right temporal T  CPS, SGTCS 95 (+) 7 yes yes 
8 right temporal T  CPS 114 (-) 3 yes no 
9 right temporal T  CPS 168 (-) 149 yes yes 
10 right medial temporal lesion T  SPS 36 (+) 31 yes yes 
11 left 
hippocampus 
T  CPS, 
SGTCS 





T  CPS 59 (+) 14 yes yes 
13 right temporal T  ? ? ? yes no 





95 (+) 44 no no 









75 (+) 45 no yes 
17 right temporal T  CPS 95 (-) 23 no no 
18 right temporal lesion T  SPS 34 (+) 39 no yes 
19 left entorhinal cortex T  
CPS with 











ET CPS 26 (+) 11 no no 
22 right parietal ET CPS, SGTCS 200 (-) 150 no no 
23 right temporo-parietal ET 
CPS, 
SGTCS 64 (+) 69 no yes 



















ET SPS 5 (+) 19 no no 
25 poor localization U CPS 65 (+) 10 yes no 
26 right hemisphere U CPS 95 (+) 10 yes yes 






24 (+) 52 yes yes 







119 (-) 22 yes no 





U CPS 100 (+) 60 no no 
30 left parieto-
occipital (?) 
U CPS, sGTCS 188 (+) 40 no yes 
31 left frontal (?) U CPS 35 (+) 15 no no 
32 poor localization U tonic 25 (+) 87 no yes 
33 hypothalamic 
hamartoma (?) 
U CPS 36 0 no yes 









94 (-) 9 no yes 
35 poor localization U ? ? ? no yes 
36 left hemisphere U CPS 62 (+) 131 no yes 
37 left frontal (?) U SPS or CPS 9 (+) 25 no no 







40 (+) 107 no yes 
39 left temporal (?) U CPS 244 (-) 146 no no 
40 left temporal (?) U CPS 110 (-) 41 no yes 
Clinical features:  Clinical information for each subject is presented in Table 1.  19/40 (48%) patients had 
temporal lobe seizures, 5/40 (13%) had extra-temp oral seizures, and the remaining 16/40 (40%) had 
uncertain seizure onset.  The majority of patients (33/40; 83%) were injected for ictal SPECT scanning 
during a complex partial seizure (CPS).  In 7 patients, a CPS evolved into a secondarily generalized tonic-
clonic seizure (sGTCS).  The remaining patients had simple partial seizures (SPS; 5/40; 13%), tonic 
Table 1.  Relevant clinical information for the 40 study subjects.  Localization category refers to 
location of seizure onset; all seizures were categorized as arising in the temporal lobe (T), 










































greater than 20%, 
13/18 had seizure 
onset in the 








Figure 5.  Example of a SPECT difference image super-imposed on an 
MRI.  This patient had left temporal lobe seizures with marked 
hyperperfusion in the right medial thalamus, as seen in the coronal 
section above.  These images were taken from patient 5 in Table 1.  
Note that the late SPECT injection (45 seconds post-ictal) is associated 
with activation of the contralateral medial thalamus.  
seizures (1/40; 3%), or seizures that were difficult to classify (3/40; 8%).  Seizures lasted between 5 and 
244 seconds with a mean duration of 84.1±59.1 seconds.  In 29/43 (67%) seizures, the injection occurred 
after the end of the 
electrographic seizure.  Late 
injections were made 
between 7 and 131 seconds 
after seizure cessation with a 
mean delay of  39.1±29.9 
seconds.  In 11/43 (26%) 
seizures, the injection 
occurred prior to seizure 
cessation or at the moment 
the seizure ended.  Injections 
were made as early as 180 seconds before seizure cessation.  On average, early injections took place 
57.3±71.8 seconds prior to the termination of ictal activity.          
SPECT findings:  Previous studies at Yale have shown that the epileptogenic area can often be identified by 
excess post-ictal 
hypoperfusion >20% that 
lasts as long as 100 
seconds after the end of 
the seizure 16.  Because 
it is known that changes 
of at least this magnitude 
are clinically important, 
changes in SPECT signal 
of more than 20% were 
accepted as significant 





Perfusion changes in the medial thalamus 
 Ipsilateral Contralateral 
Injection prior to 30 seconds 
post-ictal 7 1 




Perfusion changes in the brainstem reticular formation 
 Ipsilateral Contralateral 
Injection prior to 30 seconds 
post-ictal 6 1 
Injection after 30 seconds post-
ictal 1 (bilateral) 4 
 
Table 2.  Association of laterality and injection timing.  In patients with temporal lobe seizures, 
injection timing was strongly associated with the side of perfusion changes such that early injections 
showed ipsilateral changes while later injections showed contralateral changes.  This was true for 
changes in the medial thalamus and brainstem reticular formation. 
As shown in Table 1, medial thalamic changes of greater than 20% (and as large as 116%) were 
seen unilaterally or bilaterally in 18 of 43 (42%) seizures.  Pontomesencephalic reticular formation changes 
of greater than 20% (and as large as 77%) were seen unilaterally or bilaterally in 27 of 43 (63%) seizures.  
Interestingly, perfusion changes in thes e regions were observed to correlate with seizure localization 
(Figures 5 and 6).  Of patients with medial thalamus changes of more than 20%, 13 of 18 (72%) had seizure 
onset in the temporal lobe.  Only 1 of 18 (6%) had confirmed extra -temporal seizure onset.  The remaining 
4 patients had poorly localized seizures.  In patients without significant medial thalamus changes, seizure 
onset was more likely to occur in extra -temporal regions or to be unknown.  Of the 25 seizures in which 
significant medial temporal changes were absent, 6 had temporal onset, 6 extra -temporal onset, and the 
remaining 13 were poorly localized (Figure 6).  Thus, medial thalamic perfusion changes greater than 20% 
may be strongly predictive of temporal lobe epilepsy, although not all patients with temporal lobe epilepsy 
show these changes.  The sensitivity, specificity, and positive predictive value (PPV) of these changes for 
the diagnosis of temporal lobe epilepsy are 68%, 79%, and 72%, respectively.    
Timing and Laterality:  In patients with temporal lobe seizures, the side of greater medial thalamic 
involvement was strongly related to SPECT injection timing (Table 2).  Thus, 7 of 8 patients (patients 1, 2, 
4, 6, 7, 8, 9, and 12) injected ictally or within 30 seconds of electrographic seizure termination showed 
greater medial thalamic changes ipsilateral to the side of seizure onset.  Only patient 2 had contralateral 





represented by the ictal SPECT scan could not be located.  In contrast, 4 of 4 patients (patients 3, 5, 10, and 
11) injected more than 30 seconds after seizure termination showed greater medial thalamic changes 
contralateral to the seizure focus.  The midbrain and pontine reticular formation also showed a sequential 
pattern of ipsilateral followed by contralateral changes (Table 2).  6 of 7 patients (patients 1, 2, 6, 7, 9, 12, 
and 19) injected ictally or within 30 seconds of seizure termination had greater brainstem tegmentum 
changes ipsilateral to the side of seizure onset.  Again, only patient 2 had contralateral perfusion changes.  4 
of 5 patients (patients 5, 10, 11, 16, and 18) injected more than 30 seconds after seizure termination had 
greater brainstem tegmentum changes contralateral to the side of seizure onset.  Only patient 11 showed 
bilateral changes.  Thus, sequential activation of ipsilateral followed by contralateral thalamus and 
brainstem reticular formation was observed in the vast majority of patients.  This phenomenon may reflect 






 Though epilepsy has long been considered a disorder of cerebral cortical dysfunction, a variety of 
animal and human studies have demonstrated the importance of thalamic and brainstem structures in 
seizures.  The recent success of vagus nerve stimulation in controlling seizures and even preventing them 
after an aura has begun is particularly strong evidence in support of a role for these subcortical structures 2.  
Some of these regions, particularly medial thalamus and pontomesencephalic reticular formation, are also 
known to play a role in regulation of consciousness.  Early studies demonstrate that destruction of these 
areas render cats somnolent and inhibit low-voltage fast EEG activity typically seen in the waking state 45, 
50.  Furthermore, blood flow changes in these areas in humans correlate with level of consciousness 46.  
Because of the extensive connections known to exist between these structures and cortex, an interesting 
hypothesis suggests that medial thalamus and brainstem reticular formation are important for changes in 
consciousness during epileptic seizures.  Since much of cortex is spared of electrical involvement during 
partial seizures, it is difficult to account for the impairment of consciousness that often occurs.  If, however, 
deep brainstem and thalamic structures are electrically activated during seizures, they may depress cortical 
activity through their widespread anatomical connections and thereby affect consciousness as one typically 
observes during generalized seizures. 
 To investigate this hypothesis, we utilized SPECT ictal-interictal difference imaging in 40 patients 
with intractable epilepsy.  We demonstrated that 42% and 63% of the 43 seizures analyzed exhibited 
perfusion changes in the medial thalamus and pontomesencephalic reticular formation, respectively.  
Interestingly, of the patients with significant medial thalamus changes, 72% had temporal lobe seizure 
onset, whereas only 24% of patients without these changes had temporal lobe onset.  Finally, we showed 
that SPECT injection timing was strongly associated with laterality of changes in the medial thalamus.  
Seizures with true ictal or early post-ictal injections were much more likely to show medial thalamus 
involvement ipsilateral to the seizure focus.  Late injections, however, were much more likely to show 
contralateral involvement. 
 A number of conclusions may be drawn from this data.  First, focal perfusion changes in thalamic 
and brainstem regions support involvement of these structures in human epilepsy.  Additionally, the 





between limbic temporal structures and medial thalamus.  Finally, sequential involvement of ipsilateral 
followed by contralateral structures in the medial thalamus and upper brainstem may explain how seizures 
produce peri-ictal loss of consciousness despite incomplete involvement of the cerebral cortex.  
 Several important questions pertaining to each of these conclusions remain to be answered by 
future investigations.  Though this data supports involvement of thalamic and brainstem structures in 
epilepsy, significant perfusion changes in these regions were not observed in every patient.  Rather, medial 
thalamus changes were observed in 42% of patients, and brainstem reticular formation changes occurred in 
63%.  It is likely that these low numbers result from the heterogeneity of this patient group.  Because a 
variety of seizure types are represented and because there are relatively few patients with each of these 
seizure types, one may fail to notice an important trend that occurs in one subset of patients.  This explains 
why it was critical to conduct a subgroup analysis in which changes in the medial thalamus and brainstem 
were examined based on seizure localization.  Indeed, when patients with significant medial thalamus 
changes were analyzed separately, it became clear that the majority of them (72%) had temporal lobe 
seizure onset.  This leaves 28% of patients with significant medial thalamus changes and extra-temporal or 
unknown seizure onset.  The mechanism by which medial thalamus becomes activated in these patients is 
unclear, and the impact this activation has on consciousness is not known. 
 The finding of sequential involvement of ipsilateral followed by contralateral thalamus and 
brainstem activation is unexpected and intriguing.  There is no published data to suggest that the two sides 
of the thalamus or brainstem have unique functions with respect to seizure propagation or loss of 
consciousness.  Of course, it is logical to assume that the side ipsilateral to the seizure focus would become 
involved first.  This side is physically closest to the seizure focus and has the strongest anatomical 
connectivity.  However, it is not clear why the ipsilateral side returns to normal levels of perfusion when 
the contralateral side becomes activated.  Furthermore, the path of propagation of electrical activation from 
one side of the thalamus or brainstem to the other is unknown. 
 Ideally, in future studies one would have a large cohort of patients with proven temporal lobe 
epilepsy and an equally large cohort of patients with extra -temporal epilepsy.  To be certain that the seizure 
localization is correct, one should select patients who have undergone epilepsy surgery and achieved 





difficult to generalize the results because of the relatively small number of patients and also because a wide 
variety of epilepsy and seizure subtypes are represented.  By creating “pure” patient groups, one could 
better understand in which patients thalamic and brainstem perfusion changes are important.  In addition, it 
would be helpful to choose patients with both simple and complex partial seizures.  Considering that a chief 
aim of this study was to evaluate the role of thalamic and brainstem structures in consciousness, one should 
directly compare seizures in which consciousness is maintained with seizures in which consciousness is 
impaired or lost.  There were too few patients with simple partial seizures in our study to draw definitive 
conclusions.  In an ideal study, one could use rigorous statistical techniques to compare groups of patients 
with surgery-proven temporal lobe epilepsy and simple partial or complex partial seizures only.  There is a 
statistical software package, Statistical Parametric Mapping (SPM), that allows users to average SPECT 
scans across several patients and then analyze these averaged scans to assess statistical significance of 
group differences.  However, such a system requires that each patient’s MRI be modified so as to be super-
imposed on a standard reference MRI.  It also requires that each group of patients be as homogeneous as 
possible.  Because of time constraints, the SPM system was not a viable option for data analysis in this 
study.   
 This study has one additional shortcoming that must be mentioned.  Because the measurement of 
perfusion relies on SPECT imaging, the anatomical resolution is limited.  Typical SPECT scanning used in 
clinical situations allows one to discriminate between points that are approximately 7 mm apart 51.  
Therefore, although it is realistic to determine that changes occur in the medial thalamus or in the brainstem 
reticular formation, it would not be scientifically sound to assess changes in small subdivisions of these 
regions.  Although we believe, for example, that the mediodorsal and intralaminar nuclei are included in 
ROIs around the medial thalamus, the medial thalamus measures approximately 1 cm in diameter, so it  is 
impossible to determine which of these substructures are responsible for the measured perfusion changes.  
However, SPECT remains an extremely powerful imaging technique for this type of study because it is the 
only modality that allows for routine measurement of ictal blood flow.  Only under rare circumstances can 
one capture an ictal image with PET or fMRI scanning.      
 Though important questions remain to be answered, this study sheds light on the impact of 





which seizure types preferentially activate these structures and how electrical activity propagates to them.  
As the anatomic resolution of SPECT and other imaging techniques improve, researchers will be able to 
examine subcortical structures more closely and perhaps identify critical subregions of thalamus and 
reticular formation that are important in maintenance of consciousness.  Perhaps most exciting, functional 
studies of this sort may ultimately reveal the true neural substrate of consciousness.  With this information 
in hand, neurologists will be in a position to better understand disorders of consciousness such as epilepsy, 
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